In vivo performance of a drug-eluting contact lens to treat glaucoma for a month
Joseph B. Ciolino(Massachusetts Eye and Ear Infirmary), Daniel S. Kohane(Boston Children's Hospital), Kate A. Wymbs(Boston Children's Hospital), Cristina Ştefănescu(Massachusetts Eye and Ear Infirmary), Borja Salvador‐Culla(Massachusetts Eye and Ear Infirmary), Eden M. Ford(Boston Children's Hospital), Shireen S. Rudina(Boston Children's Hospital), Sunia A. Trauger(Harvard University), Sarah L. Sprague(Boston Children's Hospital), Priscila Cortez(Boston Children's Hospital), Fabiano Cade(Massachusetts Eye and Ear Infirmary), Amy E. Ross(Massachusetts Eye and Ear Infirmary), Daniel R. Mascoop(Boston Children's Hospital)
Cited by 199
Related Papers
Hydrogels in drug delivery: Progress and challenges
|Polymer|2008|3.7k
METLIN
|Therapeutic Drug Monitoring|2005|2.2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
|Cell stem cell|2009|1.8k
Nanotechnological strategies for engineering complex tissues
|Nature Nanotechnology|2010|1.4k